Literature DB >> 27618536

Vitamin D pathway regulatory genes encoding 1α-hydroxylase and 24-hydroxylase are dysregulated in sinonasal tissue during chronic rhinosinusitis.

Jenna M Christensen1, Jasmine Cheng1, Peter Earls2, Jenny Gunton3, William Sewell3, Raymond Sacks4,5, Richard J Harvey1,4.   

Abstract

BACKGROUND: Vitamin D deficiency is associated with many inflammatory respiratory disease states. However, serum vitamin D concentrations may not reflect tissue-specific availability. In this study we sought to assess the local expression of genes essential in vitamin D regulation in chronic rhinosinusitis (CRS).
METHODS: A cross-sectional study of adult patients undergoing endoscopic sinus surgery was performed. Patients were defined as having CRS with polyps (CRSwNP) or without polyps (CRSsNP), or normal sinus mucosa. Sinus mucosal biopsies were assessed using quantitative polymerase chain reaction to determine expression of genes encoding the vitamin D receptor (VDR), 25-hydroxylase (CYP2R1), 1α-hydroxylase (CYP27B1), and 24-hydroxylase (CYP24A1). Expression levels correlated with serum 25(OH)D [sum 25(OH)D2  and 25(OH)D3 ], the 22-item Sinonasal Outcome Test (SNOT-22), and Nasal Symptom Score (NSS). Separate analyses were performed for patients grouped by tissue eosinophilia.
RESULTS: Thirty-one patients were assessed (age 49.47 ± 18.14 years, 48.4% female), including 8 CRSsNP, 10 CRSwNP, and 13 controls. CRSsNP and CRSwNP mucosa exhibited decreased CYP27B1 compared with controls (0.0437 [Interquartile range (IQR) 0.0999] vs 0.3260 [IQR 2.9384] vs 0.6557 [IQR 1.1005], p = 0.039), whereas CYP24A1 was upregulated (0.8522 [IQR 1.3170] vs 1.2239 [IQR 4.4197] vs 0.1076 [IQR 0.1791], p = 0.025). CYP24A1 was upregulated in both non-eosinophilic CRS and eosinophilic CRS (1.1337 [IQR 2.3790] vs 0.9555 [IQR 3.2811] vs 0.1076 [IQR 0.1791], p = 0.033). Significant correlations were observed between NSS and CYP2R1 (r = -0.432, p = 0.022), CYP24A1 (r = 0.420, P = 0.026), and VDR (r = 0.425, p = 0.024), although no correlations with serum 25(OH)D were observed.
CONCLUSIONS: The local regulation of vitamin D in sinonasal tissue during CRS may be independent of serum 25(OH)D levels. Vitamin D may be dysregulated at multiple levels, with decreased transcription of the metabolic gene CYP27B1 and increased transcription of the catabolic gene CYP24A1 observed.
© 2016 ARS-AAOA, LLC.

Entities:  

Keywords:  chronic rhinosinusitis; eosinophilic rhinosinusitis and nasal polyposis; paranasal sinuses; patient-reported outcome measure

Mesh:

Substances:

Year:  2016        PMID: 27618536     DOI: 10.1002/alr.21852

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  5 in total

1.  Dietary vitamin D3 deficiency exacerbates sinonasal inflammation and alters local 25(OH)D3 metabolism.

Authors:  Jennifer K Mulligan; Whitney N Pasquini; William W Carroll; Tucker Williamson; Nicholas Reaves; Kunal J Patel; Elliott Mappus; Rodney J Schlosser; Carl Atkinson
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

2.  Chronic rhinosinusitis with polyposis and serum vitamin D levels.

Authors:  F Bavi; R Movahed; M Salehi; S Hossaini; M Bakhshaee
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

Review 3.  Nuclear Receptors in Asthma: Empowering Classical Molecules Against a Contemporary Ailment.

Authors:  Drishti Tiwari; Pawan Gupta
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

4.  Assessment of suitable reference genes for RT-qPCR studies in chronic rhinosinusitis.

Authors:  Tsuguhisa Nakayama; Naoko Okada; Mamoru Yoshikawa; Daiya Asaka; Akihito Kuboki; Hiromi Kojima; Yasuhiro Tanaka; Shin-Ichi Haruna
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

5.  Correlation of Serum Vitamin D Levels with Chronic Rhinosinusitis Disease Severity.

Authors:  Vahid Zand; Mohammadhossein Baradaranfar; Sedighe Vaziribozorg; Mohammad Mandegari; Mahzad Mansourimanesh; Nasir Saeidieslami
Journal:  Iran J Otorhinolaryngol       Date:  2020-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.